Chan Alice Y K, Li Edmund K, Tam L S, Cheng Gregory, Choi Paul C L
Rheumatology Unit, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Rheumatol Int. 2005 Jun;25(5):388-90. doi: 10.1007/s00296-004-0521-6. Epub 2004 Nov 25.
We describe a middle-aged Chinese systemic lupus erythematosus (SLE) patient developing steroid refractory and transfusion dependent red cell aplasia. Oral danazol 200 mg twice per day was started together with low-dose prednisolone therapy. There was no further recurrence of anemia 1 month after this combined therapy.
我们描述了一名中年中国系统性红斑狼疮(SLE)患者,该患者出现了类固醇难治性且依赖输血的纯红细胞再生障碍。开始每天两次口服达那唑200毫克,并联合小剂量泼尼松龙治疗。联合治疗1个月后贫血未再复发。